# A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis

> **NCT00717769** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 270 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** SUN13834
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00717769
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-16
- **Primary completion:** 2009-04-09
- **Final completion:** 2009-04-09
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2021-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717769, "A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00717769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*